Edward J. Weinstein

Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA.

Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA.

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA.

Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI.

Kypha, Inc. engages in the development of devices and products to monitor and treat inflammatory and autoimmune disorders. Its products include Comp act, RapiPlex, and sample stabilization. The company was founded by Paul K. Olson and Chad M. Stiening on January 14, 2011 and is headquartered in St. Louis, MO.

GenapSys, Inc. develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing. It also develops gene electronic nano-integrated ultra-sensitive platform device for chip-based DNA sequencing. The company was founded by Hesaam Esfandyarpour in 2010 and is headquartered in Redwood, CA.

Apse, Inc. offers technology and strategy services. It develops technology that will allow the cost efficient production of RNA for broad acre topical RNAi uses in agriculture. The company was founded by Juan Arhancet in 2011 and is headquartered in St. Louis, MO.

Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts.

Part of Incyte Corp., Genome Systems, Inc. is a company that researches and develops biotechnical products. The company is based in St. Louis, MO. The company was founded by David Adam Smoller. Genome Systems was acquired by Incyte Corp. on July 23, 1996 for $7.33 million.

Thompson Street Capital Managers LLC (Thompson Street Capital) is a private equity subsidiary of Thompson Street Capital Partners LLC, founded in 2000 by James A. Cooper and Peter Finley. The firm is headquartered in St. Louis, Missouri.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

PLUS Diagnostics, Inc. provides comprehensive pathology services. The firm specializes in genitourinary and gastrointestinal pathology, breast pathology, dermatopathology, hematopathology, oral and maxillofacial pathology. The company was founded in 1990 and is headquartered in Union, NJ.

Adarza BioSystems, Inc. develops and manufacturers a multiplex immunoassay technology that can identify proteins and genetic markers in medical specimens. The firm operates as a medical diagnostics company which also develops a rapid and label-free biological assay platform for measuring clinical and point-of-care samples and also its technology allows hundreds of tests to be run simultaneously on a single chip. The company was founded by Benjamin L. Miller, Randolph R. Henke, Terry Gronwall and Christopher C. Striemer in 2008 and is headquartered in St. Louis, MO.

Alcami Carolinas Corp. operates as a pharmaceutical development and manufacturing company. It offers development, biopharmaceutical, and analytical testing services. The company was founded in 1979 and is headquartered in Wilmington, NC.

Sigma-Aldrich Co. is a privately held life science and technology company. They produce chemical and biochemical products and kits for scientific research. The company was founded in 1934 and is headquartered in Saint Louis, MO

PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium.

Nexcelom Bioscience LLC operates as a cell counting solution company. It manufactures, designs, and develops devices and instruments for cell-cased assay used in cancer research and drug discovery. The firm offers Cellometer mini cell viability, Cellometer auto 1000 cell viability counter, Cellometer auto 2000 cell viability counter, cell-based assay kits, and Nexcelom ULA round bottom multi-well plates products. The company was founded by Jean Qiu in 2003 and is headquartered in Lawrence, MA.

Water Street Healthcare Partners LLC (Water Street Healthcare Partners) is a private equity firm founded in 2005. The firm is headquartered in Chicago, Illinois.

Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri.

Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA.

OEP Capital Advisors LP (OEP Capital Advisors) is an Private Equity firm founded by Dick Cashin in 2001. The firm is headquartered in New York with additional offices in Frankfurt and Amsterdam.

LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA.

Part of American Laboratory Products Co. Ltd., GeneProof AS is a biotechnological company based in Brno, Czechia. GeneProof develops, produces, and distributes technologically advanced, high-quality, user-friendly, and affordable PCR products for molecular in vitro diagnostics of serious infections and genetic diseases. The Czech company was founded in 2005 by Milos Dendis and Radek Horvath, who has been the CEO since then. GeneProof was acquired by American Laboratory Products Co. Ltd. on April 21, 2022.

Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden.

NEOMED-LABS, Inc. engages in operation of a contract research organization. It offers clinical immunology laboratory services. The company was founded by Max Fehlmann in March 4, 2015 and is headquartered in Montréal, Canada.

Jumpcode Genomics, Inc. provides healthcare services. The company is headquartered in Carlsbad, CA.

Laboratoires Nexelis Canada, Inc. develops immunology evaluation for vaccine and immunotherapy. It offers protein services, immunochemistry, and bioanalytical services. The company was founded by Danielle Poirier in 1989 and is headquartered in Laval, Canada.

Azurity Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on the needs of patients, especially children and the elderly, requiring customized, user-friendly drug formulations. The firm?s products include Epaned, Qbrelis, Xatmep and FIRVANQ oral solutions. The company was founded in 1998 and is headquartered in Woburn, MA.

Leinco Technologies, Inc. is a specialty manufacturer of early discovery research products, including antibodies, recombinant proteins, ELISA kits, and other life sciences products. Leinco Technologies is based in St. Louis, MO, and operates out of a 27,000 square foot facility with significant laboratory space to service all customer and regulatory requirements. The company also offers a full suite of custom development and manufacturing services and serves leading drug discovery and in vitro diagnostic companies around the world. The company was founded in 1992 by Patrick Leinert, who has been the CEO since then.

Solis Agrosciences, Inc. is a plant sciences company located in the 39N Innovation District. The American company offers technology and research services to agricultural innovators with the goal of designing and delivering new biotech plant traits in multiple crops using their proprietary Plant Pipeline as a Service (PPaaS™) for gene-edited and transgenic plant generation and characterization. Solis has a team of experienced scientists, entrepreneurs, and agtech leaders to support research needs and accelerate agricultural innovation to solve food and climate challenges. The company was founded by Charlie W. Bolten and the CEO is Tom Cohen.